08048036315
VOMIFORD 4 MD Supplier & Exporter from India to Australia - Adelaide South | Phoenix Exim

1. General Information

VOMIFORD 4 MD is an antiemetic medicine containing Ondansetron 4 mg. It is an orally disintegrating tablet designed to dissolve in the mouth and is prescribed for the prevention and management of nausea and vomiting. It is commonly used in patients experiencing nausea and vomiting associated with cancer chemotherapy, radiation therapy, and surgical procedures.

It is a prescription-only medicine, and the appropriate dose and duration should be determined by a qualified healthcare professional.

2. Product Information

  • Brand Name: VOMIFORD 4 MD
  • Active Ingredient: Ondansetron
  • Strength: 4 mg
  • Dosage Form: Orally disintegrating tablet
  • Therapeutic Class: Antiemetic
  • Route: Oral
  • Manufacturer/Marketer: Leeford Healthcare Ltd
  • Prescription Status: Prescription medicine
  • Storage: Store as directed, generally below 30°C and protected from moisture.

3. Uses of VOMIFORD 4 MD

VOMIFORD 4 MD may be prescribed for:

  • Prevention and control of nausea and vomiting caused by chemotherapy
  • Prevention of nausea and vomiting associated with radiation therapy
  • Prevention and treatment of post-operative nausea and vomiting
  • Management of nausea and vomiting associated with certain medical conditions, as determined by a doctor.

4. Benefits of This Medicine

The main benefit of VOMIFORD 4 MD is its ability to help control nausea and vomiting.

Key benefits include:

  • Helps prevent nausea and vomiting
  • Useful during cancer chemotherapy and radiotherapy
  • Helps manage nausea following surgical procedures
  • Mouth-dissolving formulation can be convenient when swallowing tablets is difficult
  • May help reduce fluid and nutrient loss associated with repeated vomiting

Ondansetron works by blocking serotonin signals involved in triggering the vomiting reflex.

5. Side Effects of VOMIFORD 4 MD

Like other medicines, VOMIFORD 4 MD may cause side effects in some people. These can vary depending on the individual and the reason for treatment.

Possible side effects include:

  • Headache
  • Constipation
  • Diarrhea
  • Tiredness or weakness
  • Drowsiness
  • Hiccups
  • Flushing or feeling warm

Most mild effects may resolve with time, but persistent or troublesome symptoms should be discussed with a healthcare professional.

6. Common Side Effects

Commonly reported side effects include:

  • Headache
  • Constipation
  • Weakness
  • Tiredness
  • Drowsiness
  • Diarrhea
  • Hiccups

Seek urgent medical attention for symptoms such as fainting, severe dizziness, or an abnormal/irregular heartbeat, as ondansetron can affect cardiac rhythm in susceptible individuals.

7. How to Use VOMIFORD 4 MD

Use VOMIFORD 4 MD only according to your doctor's prescription.

Because it is an orally disintegrating tablet:

  1. Keep your hands dry before handling the tablet.
  2. Carefully remove the tablet from the blister.
  3. Place the tablet directly on the tongue.
  4. Allow it to dissolve.
  5. Swallow with saliva; water is generally not required for the mouth-dissolving formulation.

The timing and frequency depend on the condition being treated. For chemotherapy, radiotherapy, or surgery, the doctor may instruct you to take the medicine before treatment and additional doses afterward. Do not take more than the prescribed dose.

8. How This Medicine Works

VOMIFORD 4 MD contains Ondansetron, a selective 5-HT3 serotonin receptor antagonist.

Certain treatments, including chemotherapy and radiation therapy, can cause the body to release serotonin. Serotonin can activate receptors involved in the vomiting reflex. Ondansetron blocks these serotonin signals, helping reduce the sensation of nausea and the likelihood of vomiting.

9. Safety Advice

  • Prescription use: Take only as directed by your doctor.
  • Heart conditions: Tell your doctor if you have an irregular heartbeat or other heart-rhythm problems, as ondansetron can affect the QT interval.
  • Liver problems: Inform your doctor if you have liver disease; dosage adjustment may be necessary in severe hepatic impairment.
  • Medicines: Inform your doctor about all medicines you take, particularly medicines for heart conditions, epilepsy, cancer, or depression.
  • Apomorphine: Ondansetron should not be used with apomorphine because of the risk of severe hypotension and loss of consciousness.
  • Pregnancy: Consult your doctor before use during pregnancy.
  • Breastfeeding: Discuss use with your healthcare professional before breastfeeding.
  • Driving: If you experience dizziness, drowsiness, or visual disturbances, avoid driving or operating machinery.
  • Storage: Keep in a dry place and follow the storage conditions stated on the product packaging.

10. Frequently Asked Questions (FAQs)

Q1. What is VOMIFORD 4 MD used for?
VOMIFORD 4 MD is used to prevent and control nausea and vomiting, particularly those associated with chemotherapy, radiation therapy, and surgery.

Q2. What is the active ingredient in VOMIFORD 4 MD?
It contains Ondansetron 4 mg.

Q3. Is VOMIFORD 4 MD a mouth-dissolving tablet?
Yes. It is an orally disintegrating formulation designed to dissolve in the mouth.

Q4. Can VOMIFORD 4 MD be taken with food?
Ondansetron can generally be taken with or without food, but follow your doctor's specific instructions.

Q5. Does VOMIFORD 4 MD stop all types of vomiting?
No. Its effectiveness depends on the underlying cause. It is particularly used for nausea and vomiting associated with chemotherapy, radiotherapy, surgery, and certain other conditions.

Q6. Can I take VOMIFORD 4 MD during pregnancy?
Do not self-medicate during pregnancy. Consult your doctor, who can assess whether ondansetron is appropriate for you.

Q7. What should I do if I miss a dose?
Take the missed dose when remembered unless it is nearly time for the next dose. Do not double the dose. Follow your doctor's instructions.

Q8. Can VOMIFORD 4 MD be taken with other medicines?
It may interact with certain medicines. Tell your doctor about all prescription medicines, over-the-counter medicines, and supplements you are taking.

11. Substitute for VOMIFORD 4 MD

Possible substitutes are products containing the same active ingredient and strength, Ondansetron 4 mg, but the dosage form and inactive ingredients may differ.

Examples listed as substitutes include Rx Eterna MD 4 Tablet, Nuavomin-4 mg Tablet, and Vominil-MD 4 mg Tablet.

Important: Do not switch brands or formulations without confirming with your doctor or pharmacist, particularly when the medicine is being used around chemotherapy, radiotherapy, or surgery.

12. SEO Keywords

  1. VOMIFORD 4 MD exporter from India
  2. VOMIFORD 4 MD tablets supplier
  3. Ondansetron 4 mg exporter India
  4. Ondansetron 4 mg tablets supplier
  5. Ondansetron mouth dissolving tablets exporter
  6. VOMIFORD 4 MD wholesale supplier
  7. VOMIFORD 4 MD medicine exporter
  8. Anti nausea medicine exporter India
  9. Anti vomiting tablets supplier India
  10. Ondansetron tablets wholesale exporter
  11. Chemotherapy nausea medicine supplier
  12. Radiation nausea treatment medicine exporter
  13. Post surgery nausea medicine supplier
  14. Genuine Ondansetron 4 mg supplier
  15. Indian pharmaceutical exporter Ondansetron
  16. VOMIFORD 4 MD bulk exporter
  17. Ondansetron MD tablets India exporter
  18. Nausea and vomiting medicine supplier
  19. Prescription antiemetic medicine exporter
  20. Pharmaceutical medicine exporter Nagpur India
  21. Ondansetron 4 mg wholesale India
  22. VOMIFORD 4 MD export supply
  23. Anti-emetic tablets exporter from India
  24. Cancer treatment supportive medicine supplier
  25. Ondansetron mouth dissolving tablets supplier
  26. VOMIFORD 4 MD supplier USA
  27. VOMIFORD 4 MD supplier UK
  28. VOMIFORD 4 MD supplier Australia
  29. VOMIFORD 4 MD supplier Singapore
  30. VOMIFORD 4 MD supplier Canada
  31. VOMIFORD 4 MD supplier South Korea
  32. VOMIFORD 4 MD supplier UAE
  33. Indian pharma supplier for global markets
  34. Bulk Ondansetron medicine exporter
  35. Phoenix Exim pharmaceutical exporter
Sep 10th, 2026 2:40 PM

Keywords